About this trial
This is multi-institutional retrospective study in order to identify the most relevant clinical characteristics, treatment strategies, to explore the impact on principal clinical outcomes and finally, to suggest some principles for management and treatment of breast sarcomas.
The study will collect data about patients affected by breast sarcoma referred to participating Institutions between January 2000 and June 2020
Eligibility criteria
Qualifiers
>18 years at diagnosis
primary or secondary breast sarcoma
availability of medical data needed for the study (histopathological data, surgery, chemotherapy, including preceding chemotherapeutic regimens for secondary breast sarcomas, radiation therapy)
Disqualifiers
sarcoma metastases to the breast
chest wall sarcomas not arising in the mammary gland
cutaneous sarcomas
Trial design
Treatments tested in this trial
- Treatment of Breast Sarcoma according clinical practice (includes drugs, surgery or any other received treatments)